scholarly journals Clinical review of the efficacy and safety of oral semaglutide in patients with type 2 diabetes considered for injectable GLP-1 receptor agonist therapy or currently on insulin therapy

2020 ◽  
Vol 132 (sup2) ◽  
pp. 26-36 ◽  
Author(s):  
Eugene E. Wright Jr ◽  
Vanita R. Aroda
Keyword(s):  
Type 2 Diabetes ◽  
Insulin Therapy ◽  
Clinical Review ◽  
Receptor Agonist ◽  
Efficacy And Safety ◽  
Agonist Therapy

Efficacy and Safety of Continuing Sitagliptin when Initiating Insulin Therapy in Subjects with Type 2 Diabetes Mellitus

Diabetes ◽  
2018 ◽  
Vol 67 (Supplement 1) ◽  
pp. 112-LB ◽  
Author(s):  
RONAN ROUSSEL ◽  
SANTIAGO DURAN-GARCIA ◽  
YILONG ZHANG ◽  
SUNERI SHAH ◽  
CAROLYN DARMIENTO ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Insulin Therapy ◽  
Efficacy And Safety

scholarly journals Efficacy and Safety of ITCA 650, a Novel Drug-Device GLP-1 Receptor Agonist, in Type 2 Diabetes Uncontrolled With Oral Antidiabetes Drugs: The FREEDOM-1 Trial

Diabetes Care ◽  
2017 ◽  
Vol 41 (2) ◽  
pp. 333-340 ◽  
Author(s):  
Julio Rosenstock ◽  
John B. Buse ◽  
Rehan Azeem ◽  
Prakash Prabhakar ◽  
Lise Kjems ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Receptor Agonist ◽  
Efficacy And Safety ◽  
Oral Antidiabetes Drugs ◽  
Novel Drug

78-LB: Efficacy and Safety of Tirzepatide, a Dual GIP/GLP-1 Receptor Agonist, Compared with Insulin Degludec in Patients with Type 2 Diabetes (SURPASS-3)

Diabetes ◽  
2021 ◽  
Vol 70 (Supplement 1) ◽  
pp. 78-LB
Author(s):  
BERNHARD LUDVIK ◽  
FRANCESCO GIORGINO ◽  
ESTEBAN JODAR ◽  
JUAN PABLO FRIAS ◽  
LAURA FERNANDEZ LANDO ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Receptor Agonist ◽  
Insulin Degludec ◽  
Efficacy And Safety

GLP-1 receptor agonist added to insulin versus basal-plus or basal-bolus insulin therapy in type 2 diabetes: A systematic review and meta-analysis

2018 ◽  
Vol 35 (1) ◽  
pp. e3082 ◽  
Author(s):  
Marco Castellana ◽  
Angelo Cignarelli ◽  
Francesco Brescia ◽  
Luigi Laviola ◽  
Francesco Giorgino
Keyword(s):  
Systematic Review ◽  
Type 2 Diabetes ◽  
Insulin Therapy ◽  
Receptor Agonist ◽  
Meta Analysis ◽  
Bolus Insulin ◽  
Basal Bolus
Sign in / Sign up

Export Citation Format

Share Document